fda statement bpc-157 not approved fda.gov
fda statement bpc-157 not approved fda.gov was just voted on by the advisory panel at today’s PCAC meeting. The vote was 8 to 6 with 1 abstention in favor of recommending BPC-157 (free base) on the 503a Bulks List., #BPC-157 add-on Color:Nardo Gray Product
Baker’s notes & crumb story
Description
fda statement bpc-157 not approved fda.gov was just voted on by the advisory panel at today’s PCAC meeting. The vote was 8 to 6 with 1 abstention in favor of recommending BPC-157 (free base) on the 503a Bulks List., #BPC-157 add-on Color:Nardo Gray Product
Product
Unless your compounding pharmacy provides specific documentation that their formulation tolerates room temperature for a defined period, assume compounded tirzepatide requires constant refrigeration
add-on
Color:Nardo Gray
That is a gaping hole that we have to fill at this point.” G